All In Biotech

Drug Trial Radar · NCT06072482

A Study to Evaluate Avacopan in Participants With ANCA-associated Vasculitis

A Randomized, Double-blind, Placebo-controlled Phase 4 Clinical Trial to Evaluate the Long-term Safety and Efficacy of Avacopan in Participants With Antineutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis

Last checked: Nov 20, 2026Latest source record: Nov 13, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingRandomized with 300 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

300

Planned (sponsor's estimate)

Start

Feb 7, 2024

Primary completion

Dec 31, 2036

Study completion Dec 31, 2036

Sponsor

Lead sponsor
AmgenAmgen (AMGN)
Sponsor type
Industry
First posted
Oct 10, 2023

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 100 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The primary objective of this study is to evaluate the long-term safety of avacopan in participants with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV).

Conditions

  • Antineutrophil Cytoplasmic Antibody-associated Vasculitis

Interventions

  • AvacopanDrug

    Administered orally.

  • PlaceboDrug

    Administered orally.

  • Standard of CareDrug

    All participants will receive SoC background immunosuppressive therapy for induction and maintenance, at the discretion of the Investigator and as supported by current guidelines, product labels and local practices and informed by the individual participant's clinical condition, preferences, and values.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percentage of Participants Experiencing Treatment-emergent Adverse Events (TEAEs)Time frame: Up to Month 60
  2. Percentage of Participants Experiencing Adverse Events of Special InterestTime frame: Up to Month 60
  3. Percentage of Participants Experiencing Serious Adverse EventsTime frame: Up to Month 60
  4. Percentage of Participants Experiencing Adverse Events Leading to WithdrawalTime frame: Up to Month 60
  5. Percentage of Participants Experiencing Adverse Events Leading to DeathTime frame: Up to Month 60
  6. Number of Participants Experiencing Clinical Significant Changes from Baseline in Vital Signs MeasurementsTime frame: Up to Month 60
  7. Number of Participants Experiencing Clinical Significant Changes from Baseline in Hematology AssessmentsTime frame: Up to Month 60
  8. Number of Participants Experiencing Clinical Significant Changes from Baseline in Serum Chemistry AssessmentsTime frame: Up to Month 60
  9. Number of Participants Experiencing Clinical Significant Changes from Baseline in Urinalysis AssessmentsTime frame: Up to Month 60

Locations

82 sites in 7 countries. Site status is shown where the registry gives one.

  • Orthopedic Physicians Alaska

    Anchorage, Alaska · Terminated

  • Scottsdale Healthcare at Shea - HonorHealth

    Scottsdale, Arizona · Recruiting

  • Southwest Kidney Institute

    Surprise, Arizona · Recruiting

  • Unity Health

    Searcy, Arkansas · Recruiting

  • Medvin Clinical Research

    Covina, California · Terminated

  • Palo Alto Medical Foundation Fremont

    Fremont, California · Recruiting

  • The Nephrology Group

    Fresno, California · Recruiting

  • Providence Medical Foundation

    Fullerton, California · Recruiting

  • Southland Arthritis and Osteoarthritis Medical Center, Inc

    Menifee, California · Recruiting

  • University of California San Francisco- Zuckerburg San Francisco General

    San Francisco, California · Recruiting

  • Harbor University of California at Los Angeles Medical Center

    Torrance, California · Recruiting

  • Amicis Research Center

    Valencia, California · Recruiting

  • University of Colorado

    Aurora, Colorado · Recruiting

  • Florida Kidney Physicians

    Boca Raton, Florida · Recruiting

  • Malcom Randall Veterans Affairs Medical Center

    Gainesville, Florida · Recruiting

  • Mayo Clinic

    Jacksonville, Florida · Recruiting

  • ClinTrial Research Oakwater, Llc

    Orlando, Florida · Recruiting

  • University of South Florida

    Tampa, Florida · Recruiting

  • Emory University

    Atlanta, Georgia · Recruiting

  • Lake Cumberland Rheumatology

    New Albany, Indiana · Recruiting

  • University of Iowa Hospitals and Clinics

    Iowa City, Iowa · Recruiting

  • University of Kentucky

    Lexington, Kentucky · Recruiting

  • Johns Hopkins Bayview Medical Center

    Baltimore, Maryland · Recruiting

  • Massachusetts General Hospital

    Boston, Massachusetts · Recruiting

  • Brigham and Womens Hospital

    Boston, Massachusetts · Terminated

  • Henry Ford Health System

    Detroit, Michigan · Recruiting

  • Kidney Michigan Institute

    Saginaw, Michigan · Recruiting

  • Clinical Research Institute of Michigan

    Saint Clair Shores, Michigan · Recruiting

  • Revive Research Institute

    Sterling Heights, Michigan · Recruiting

  • University of Minnesota

    Minneapolis, Minnesota · Recruiting

  • Mayo Clinic

    Rochester, Minnesota · Recruiting

  • Renown Rheumatology

    Reno, Nevada · Recruiting

  • Dartmouth Hitchcock Medical Center

    Lebanon, New Hampshire · Recruiting

  • Renal Medicine Associates

    Albuquerque, New Mexico · Recruiting

  • New York Nephrology Vasculitis and Glomerular Center

    Albany, New York · Recruiting

  • Northwell Health

    Great Neck, New York · Recruiting

  • Hospital For Special Surgery

    New York, New York · Recruiting

  • Carolina Kidney Associates

    Greensboro, North Carolina · Recruiting

  • East Carolina University Brody Outpatient Center

    Greenville, North Carolina · Recruiting

  • Brookview Hills Research Associates Llc

    Winston-Salem, North Carolina · Recruiting

Showing 40 of 82 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.